Roche boasts of stalling lung can­cer with Tecen­triq/chemo com­bo -- but ri­val Mer­ck stays out front

CHICA­GO — Roche ar­rived at AS­CO boast­ing a sig­nif­i­cant ad­vance for treat­ing front­line cas­es of ad­vanced squa­mous non-small cell lung can­cer with a com­bi­na­tion of Tecen­triq …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER